Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ullas Batra's publication output changed over time?
ScholarIQpublication output · 2015–2024
Output grew0% over the shown period — from 1 works in 2015 to 1 in 2024.
1
3
2
3
1
1
1
2015201920202021202220232024
What are the most-cited papers on Ullas Batra?
ScholarIQmost cited works
Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study
Byoung Chul Cho, Radka Obermannová, Alessandra Bearz, Mark J. McKeage, Dong-Wang Kim, Ullas Batra, Gloria Borra, Sergey Orlov, Sang-We Kim, Sarayut Lucien Geater, Pieter E. Postmus, Scott A. Laurie, Keunchil Park, Cheng‐Ta Yang, Andrea Ardizzoni, Anna Bettini, Gilberto de Castro, Flavia Kiertsman, Zhe Chen, Yvonne Lau, Kalyanee Viraswami-Appanna, Vanessa Q. Passos, Rafał Dziadziuszko
Journal of Thoracic Oncology. 201972 CitationsOPEN ACCESS
Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
Praveen Jain, Dinesh Chandra Doval, Ullas Batra, Pankaj Goyal, Sneha Bothra, Chaturbhuj Agarwal, Dutta Kumardeep Choudhary, Abhishek Yadav, Venkata Pradeep Babu Koyalla, Mansi Sharma, Prashanta Dash, Vineet Talwar
S149902429. 201955 Citations
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer
Ullas Batra, Bivas Biswas, Kumar Prabhash, M. Vamshi Krishna
S2736820664. 202355 CitationsOPEN ACCESS
Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer
Sally C. M. Lau, Ullas Batra, Tony Mok, Herbert H. Loong
Drugs. 201954 Citations
A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery
Dinesh Chandra Doval, Radhakrishna Selvi, Rupal Tripathi, Renu Iyer Kashinath, Vineet Talwar, Ullas Batra, Naga Amulya Mullapudi, Kapil Kumar, Ajay Kumar Dewan, Harit Chaturvedi, Juhi Tayal, Anurag Mehta, Sudeep Gupta, Ramesh Nimmagadda
Scientific Reports. 202051 CitationsOPEN ACCESS
Related on ScholarIQ
Rajiv Gandhi Cancer Institute and Research Centre
Institution
Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study
Paper
Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
Paper
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer
Paper
Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer
Paper
A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery
Paper